| 5 | 1/1 | 返回列表 |
| 查看: 2899 | 回復(fù): 4 | ||
| 當(dāng)前只顯示滿足指定條件的回帖,點擊這里查看本話題的所有回帖 | ||
gaojingmei金蟲 (著名寫手)
|
[求助]
阿奇霉素片和膠囊的原研廠家?
|
|
|
阿奇霉素片和膠囊的原研廠家是究竟是哪家呢?是同一廠家?還是不同廠家?Pliva和輝瑞到底哪個才是原研廠家? 在美國是輝瑞上市早,Pliva是仿制,但在其他國家和地區(qū)的批準上市情況如何呢? 請各位大俠鼎力相助! |
鐵桿木蟲 (職業(yè)作家)
鐵桿木蟲 (職業(yè)作家)
|
Select all Show Checked azithromycin Updated on 06-MAR-2012. Originator: PLIVA dd . Highest Dev Status: Launched. DR azithromycin dihydrate + chloroquine phosphate (fixed-dose combination/ Plasmodium falciparum malaria), Pfizer/ Medicines For Malaria Venture/ London School of Hygiene and Tropical Medicine Updated on 02-MAR-2012. Originator: Medicines for Malaria Venture . Highest Dev Status: Phase 3 Clinical. DR azithromycin (ophthalmic sustained release, DuraSite), InSite Updated on 29-FEB-2012. Originator: InSite Vision Inc . Highest Dev Status: Launched. DR azithromycin (sustained-release, DuraSite, ocular infection), InSite Updated on 29-FEB-2012. Originator: InSite Vision Inc . Highest Dev Status: Discovery. DR azithromycin + dexamethasone (sustained release, DuraSite), InSite Updated on 29-FEB-2012. Originator: InSite Vision Inc . Highest Dev Status: Phase 3 Clinical. DR JP-02 Updated on 13-JAN-2012. Originator: Bioagency AG . Highest Dev Status: No Development Reported. DR azithromycin (dermal formulation, Lyme disease), Ixodes Updated on 08-SEP-2011. Originator: Ixodes Gmbh . Highest Dev Status: Phase 2 Clinical. DR azithromycin + dexamethasone (sustained-release, DuraSite, bacterial ear infection), InSite Updated on 25-AUG-2011. Originator: InSite Vision Inc . Highest Dev Status: Discontinued. DR azithromycin-based macrolide antibiotics (malaria), GlaxoSmithKline/Medicines for Malaria Venture Updated on 24-AUG-2011. Originator: GlaxoSmithKline plc . Highest Dev Status: No Development Reported. DR azithromycin (sustained release, microsphere formulation), Pfizer Updated on 31-MAY-2011. Originator: Pfizer Inc . Highest Dev Status: Launched. DR azithromycin (Solumer nanoparticle, bacterial infection), Solubest Updated on 02-SEP-2009. Originator: Solubest Ltd . Highest Dev Status: No Development Reported. |
木蟲 (職業(yè)作家)
鐵桿木蟲 (正式寫手)
| 阿奇霉素最先是由克羅地亞普利瓦公司研制合成,并率先在前南斯拉夫上市的。為了取得更大的經(jīng)濟效益,原研發(fā)公司將全球的生產(chǎn)和市場開發(fā)權(quán)進行了轉(zhuǎn)讓,由美國輝瑞公司和意大利Sigma-Tau公司授讓進行全球開發(fā)。輝瑞公司在取得了全球開發(fā)權(quán)后,其獲批的阿奇霉素商品名為希舒美。08年,希舒美在阿奇霉素的市場占有率達到30.78%。 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 一志愿南師大0703化學(xué) 275求調(diào)劑 +6 | Ripcord上岸 2026-03-27 | 6/300 |
|
|---|---|---|---|---|
|
[考研] 計算機265跨調(diào)環(huán)境 +5 | Yumeng_6 2026-03-27 | 5/250 |
|
|
[考研] 0805求調(diào)劑 +8 | 是水分 2026-03-31 | 8/400 |
|
|
[考研] 266分,一志愿電氣工程,本科材料,求材料專業(yè)調(diào)劑 +3 | 哇呼哼呼哼 2026-04-02 | 3/150 |
|
|
[考研] 366求調(diào)劑一志愿東北大學(xué) +6 | 運氣來得若有似?/a> 2026-04-02 | 6/300 |
|
|
[考研] 321求調(diào)劑 +9 | y-yh 2026-04-01 | 10/500 |
|
|
[考研] 【求調(diào)劑】新能源材料本科,一志愿211,初試321 +6 | 求調(diào)劑學(xué)校, 2026-04-02 | 6/300 |
|
|
[考研] 085410 一志愿211 22408分數(shù)359求調(diào)劑 +3 | 123456789qw 2026-03-31 | 4/200 |
|
|
[考研] 食品學(xué)碩362求調(diào)劑 +3 | xuanxianxian 2026-04-01 | 3/150 |
|
|
[考研] 266分求材料化工冶金礦業(yè)等專業(yè)的調(diào)劑 +7 | 哇呼哼呼哼 2026-03-26 | 7/350 |
|
|
[考研] 0710生物學(xué)考研調(diào)劑 +3 | 李多米lee. 2026-03-27 | 4/200 |
|
|
[考研] 085410人工智能 初試316分 求調(diào)劑 +3 | 殘星拂曙 2026-03-31 | 3/150 |
|
|
[考研] 求0861交通運輸專碩or材料專碩調(diào)劑 +4 | 勒布朗@ 2026-03-31 | 4/200 |
|
|
[考研] 288資源與環(huán)境專碩求調(diào)劑,不限專業(yè),有學(xué)上就行 +25 | lllllos 2026-03-30 | 26/1300 |
|
|
[考研] 材料工程085601數(shù)二英一335求調(diào)劑 +5 | 雙馬尾痞老板2 2026-03-31 | 5/250 |
|
|
[考研] 340求調(diào)劑 +4 | 希望如此i 2026-03-31 | 4/200 |
|
|
[基金申請] 面上5B能上會嗎? +8 | redcom 2026-03-29 | 8/400 |
|
|
[考研] 276求調(diào)劑 +3 | 趙久華 2026-03-29 | 3/150 |
|
|
[考研] 334分 一志愿武理 材料求調(diào)劑 +16 | 李李不服輸 2026-03-26 | 16/800 |
|
|
[考研] 340求調(diào)劑 +5 | jhx777 2026-03-27 | 5/250 |
|